At Worldwide Clinical Trials, our medical experts understand that the commercial viability of therapeutics for chronic respiratory disorders is influenced by a range of factors, including perceived value and therapeutic novelty. This has particular relevance to illnesses with established pharmacotherapy such as asthma and COPD. Worldwide Clinical Trials’ philosophy of employing expert clinical trial methodology, combined with our commitment to innovation, helps us deliver data relevant to multiple stakeholder perspectives and appropriate to each phase of your drug or device development.
Worldwide has completed more than 100 studies related to respiratory disorders since 2008. For these studies, Worldwide Clinical Trials provided multiple services, including clinical monitoring or project management services across all phases. We have completed trials with a wide range of therapeutic interventions, such as corticosteroids, bronchodilators, and antibiotics, as well as kinase inhibitors.